InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,114.32
(
-0.12%
)
Post# of 252199
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 153061

Wednesday, 11/28/2012 4:45:07 AM

Wednesday, November 28, 2012 4:45:07 AM

Post# of 252199
You are right of course that it is known for some time now that IL28B status is an irrelevant factor when you treat HCV with a potent DAA combo and perhaps (not sure about that) GILD were still genotyping the IL28 locus, but even if so, it would be a response predictor for INF containing treatment (predicts viral clearance) not INF intolerance. So my feeling is that these patients are a bit more intolerant to treatments in general and naïve comply better.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up